Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1663-1672

  Darcy, Phillip K ^a   Kershaw, Michael H ^a   Trapani, Joseph A ^a   Smyth, Mark J ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Cytotoxicity; Fas ligand; Signal transduction; Single chain antibody; Tumor immunity

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD8 ANTIGEN; FAS LIGAND; FC RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; COLON CARCINOMA; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CLONE CELLS; COLONIC NEOPLASMS; COS CELLS; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GENE EXPRESSION; HT29 CELLS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; INTERFERON TYPE II; JURKAT CELLS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031946483     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199805)28:05<1663::AID-IMMU1663>3.0.CO;2-L     Document Type: Article

References (34)

1. Kershaw, M. H., Trapani, J. A. and Smyth, M. J., Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer. Ther. Immunol. 1995. 2: 173-181.
2. Renner, C. and Pfreundschuh, M., Tumor therapy by immune recruitment with bispecific antibodies, Immunol. Rev. 1995. 145: 179-209.
3. Hwu, P., Yang, J. C., Cowherd, R., Treisman, J., Shafer, G. E., Eshhar, Z. and Rosenberg, S. A., In vivo antitumor activity of T cells redirected with chimeric antibody/T cell receptor genes. Cancer Res. 1995. 55: 3369-3373.
4. Moritz, D., Wels, W., Mattern, J. and Groner, B., Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4318-4322.
5. Stancovski, I., Schindler, D. G., Waks, T., Yarden, Y., Sela, M. and Eshhar, Z., Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J. Immunol. 1993. 151: 6577-6582.
6. Weijtens, M. E., Willemsen, R. A., Valerio, D., Stam, K. and Bolhuis, R. L., Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. J. Immunol. 1996. 157: 836-843.
7. Tran, A. C., Zhang, D., Byrn, R. and Roberts, M. R., Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes. J. Immunol. 1995. 155: 1000-1009.
8. Kershaw, M. H., Darcy, P. K., Trapani, J. A. and Smyth, M. J., The use of chimeric human Fc(epsilon) receptor I to redirect cytotoxic T lymphocytes to tumors. J. Leukoc. Biol. 1996. 60: 721-728
9. Smyth, M. J., Kershaw, M. H., Hulett, M. D., McKenzie, I. F. C. and Trapani, J. A., Use of the 5′-flanking region of the mouse perforin gene to express human Fc gamma receptor I in cytotoxic T lymphocytes. J. Leukoc. Biol. 1994. 55: 514-522.
10. Barbacci, E. G., Guarino, B. C., Stroh, J. G., Singleton, D. H., Rosnack, K. J., Moyer, J. D. and Andrews, G. C., The structural basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem. 1995. 270: 9585-9589.
11. Hege, K. M., Cooke, K. S., Finer, M. H., Zsebo, K. M. and Roberts, M. R., Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice. J. Exp. Med. 1996. 184: 2261-2269.
12. Gross, G., Waks, T. and Eshhar, Z., Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc. Natl. Acad. Sci. USA 1989. 86: 10024-10028.
13. Eshhar, Z., Waks, T., Gross, G. and Schindler, D. G., Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T cell receptors. Proc. Natl. Acad. Sci. USA 1993. 90: 720-724.
14. Brocker, T., Riedinger, M. and Karjalainen, K., Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor. Eur. J. Immunol. 1996. 26: 1770-1774.
15. Henkart, P. A., Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994. 1: 343-346.
16. Connors, T. A., Duncan, R. and Knox, R. J., The chemotherapy of colon cancer. Eur. J. Cancer 1995. 31A: 1373-1378.
17. Minsky, B. D., Adjuvant radiation therapy for colon cancer. Cancer Treat. Rev. 1995. 21: 407-414.
18. Blottiere, H. M., Zennadi, R., Gregoire, M., Aillet, G., Denis, M. G., Meflah, K. and Le Pendu, J., Analysis of the relationship between stage of differentiation and NK/ LAK susceptibility of colon carcinoma cells. Int. J. Cancer 1993. 53: 409-417.
19. Helgason, C. D., Prendergast, J. A., Berke, G. and Bleackley, R. C., Peritoneal exudate lymphocyte and mixed lymphocyte culture hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin. Eur. J. Immunol. 1992. 22: 3187-3190.
20. Yang, Y., Xiang, Z., Ertl, H. C. and Wilson, J. M., Up-regulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 1995. 92: 7257-7261.
21. Keane, M. M., Ettenberg, S. A., Lowrey, G. A., Russell, E. K. and Lipkowitz, S., Fas expression and function in normal and malignant breast cell lines. Cancer Res. 1996. 56: 4791-4798.
22. 2 for efficient lysis of p185HER2 overexpressing tumor cells. Int. J. Cancer 1995. 62: 319-324.
23. Blottiere, H. M., Zennadi, R., Burg, C., Douillard, J. Y., Melah, K. and Le Pendu, J., Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines. Int. J. Cancer 1992. 50: 659-664.
24. Martin, E. W., Cooperman, M. et al., A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer. Am. J. Surg. 1979. 137: 167-169.
25. Lokich, J. J., Zamcheck, N. and Lowenstein, M., Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse. Ann. Intern. Med. 1978. 39: 902-906.
26. Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H. and Leibson, P. J., Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 1996. 156: 2693-2699.
27. Anel, A., Buferne, M., Boyer, C., Schmitt-Verhulst, A. M. and Golstein, P., T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 1994. 24: 2469-2476.
28. Gonzalez-Garcia, A., Borlado, L. R., Leonardo, E., Merida, I., Martinez-A., C. and Carrera, A. C., Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 1997. 158: 4104-4112.
29. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S., Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995. 154: 3806-3813.
30. Owen-Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K. and Yonehara, S., Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 1994. 54: 1580-1586.
31. Rouvier, E., Luciani, M.-F. and Golstein, P., Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 1993. 177: 195-200.
32. Chester, K. A., Begent, R. H., Robson, L., Keep, P., Pedley, R. B., Boden, J. A., Boxer, G., Green, A., Winter, G., Cochet, O. et al., Phage libraries for generation of clinically useful antibodies. Lancet 1994. 343: 455-456.
33. Aruffo, A. and Seed, B., Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 1987. 84: 8573-8577.
34. Kershaw, M. H., Darcy, P. K., Hulett, M. D., Hogarth, P. M., Trapani, J. A. and Smyth, M. J., Redirected cytotoxic effector function. Requirements for expression of chimeric single chain high affinity immunoglobulin E receptors. J. Biol. Chem. 1996. 271: 21214-21220.